American Century Companies Inc Invitae Corp Transaction History

American Century Companies Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $1.41 Million - $5.96 Million	-661,669 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$6.28 - $15.59 $1.92 Million - $4.78 Million	306,473 Added 86.28%	661,669 $5.27 Million
Q4 2021 Feb 07, 2022	BUY	$14.7 - $28.67 $1.69 Million - $3.29 Million	114,874 Added 47.8%	355,196 $5.42 Million
Q3 2021 Nov 10, 2021	SELL	$24.31 - $33.6 $802 - $1,108	-33 Reduced 0.01%	240,322 $6.83 Million
Q2 2021 Aug 05, 2021	BUY	$26.09 - $40.4 $34,203 - $52,964	1,311 Added 0.55%	240,355 $8.11 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $7.55 Million - $13 Million	228,518 Added 2170.99%	239,044 $9.13 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $8,677 - $12,742	222 Added 2.15%	10,526 $440,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $59,930 - $94,164	2,108 Added 25.72%	10,304 $447,000
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $95,975 - $248,256	8,196 New	8,196 $248,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.